Yahoo Finance

AC Immune and Piramal Imaging Announce Out-Licensing Agreement for the Development of Tau Protein Diagnostics in Alzheimer's Disease

AC Immune SA and Piramal Imaging, a division of Piramal Enterprises Ltd., announced today that they have entered into an exclusive worldwide license agreement for the research, development and ...
Nasdaq

AC Immune Presents New Preclinical Data for Therapeutic and Diagnostic Candidates Addressing Novel Targets for Neurodegenerative Diseases

LAUSANNE, Switzerland, March 09, 2021 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative ...
Investing

AC Immune's Tau-PET diagnostic gets FDA fast track

LAUSANNE, Switzerland - AC Immune SA (NASDAQ:ACIU), a biopharmaceutical company specializing in neurodegenerative diseases, has received Fast Track Designation from the U.S. Food and Drug ...
technologynetworks

AC Immune, Nestlé Institute of Health Sciences Collaborate

Under the terms of the agreement AC Immune will provide its world leading expertise in the biology and pathology of Tau as well as committing its laboratory capabilities to support the collaborative ...